Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2012
11/01/2012WO2012148846A1 Combination of a phosphatidylinositol-3-kinase (pi3k) inhibitor and a mtor inhibitor
11/01/2012WO2012148808A1 Aldosterone synthase inhibitors
11/01/2012WO2012148792A1 Heterocyclic compounds as b-raf inhibitors for treatment of cancer
11/01/2012WO2012148775A1 Bicyclic pyridazine compounds as pim inhibitors
11/01/2012WO2012148588A2 CRYSTAL FORM OF N-{3-[5-(2-AMINO-4-PYRIMIDINYL)-2-(1,1-DIMETHYLETHYL)-1,3-THIAZOL-4yl}-2-FLUOROPHENYL}-2,6-DIFLUOROBENZENESULFONAMIDE
11/01/2012WO2012148553A1 Process for the preparation of an orexin receptor antagonist
11/01/2012WO2012148550A1 Prodrugs of therapeutic compounds
11/01/2012WO2012148548A1 N-substituted oxazinopteridines and oxazinopteridinones
11/01/2012WO2012148540A1 Combination of kanase inhibitors and uses threof
11/01/2012WO2012148308A1 Pharmacologically active alicyclic ν,ν'-substituted 3,7-diazabicyclo[3.3.1]nonane derivatives and drugs based thereon
11/01/2012WO2012148295A1 Antiviral drug derivative
11/01/2012WO2012148277A1 Method for isolation of polysaccharides
11/01/2012WO2012148247A2 Pharmaceutical composition containing oleanolic acid acetate as an active ingredient for preventing or treating tlr- or il-6-mediated diseases
11/01/2012WO2012148246A2 A preparation method of sitagliptin
11/01/2012WO2012148225A2 Sustained-release pharmaceutical composition comprising donepezil or pharmaceutically acceptable salt thereof having improved dissolution stability and method for manufacturing the same
11/01/2012WO2012148148A2 Novel zinc azide complex and a process for preparing tetrazole derivatives using the same
11/01/2012WO2012148140A2 Imidazole-based alkaloid derivatives which have angiogenesis inhibition and antioxidant effects and production method thereof
11/01/2012WO2012148002A1 Method for modulating ion transporter
11/01/2012WO2012147986A1 Stable pharmaceutical composition
11/01/2012WO2012147916A1 Amide compound and pharmaceutical application therefor
11/01/2012WO2012147902A1 Antiarrhythmic drug, atrial fibrillation inhibitor, model of sustained atrial fibrillation and method for producing same, and method for screening atrial fibrillation inhibitor
11/01/2012WO2012147901A1 Composition for mitigating anticancer drug side effects
11/01/2012WO2012147890A1 Novel azole derivative
11/01/2012WO2012147861A1 Composition for inhibiting endoserine-1 production and composition for promoting cell proliferation
11/01/2012WO2012147842A1 Beautiful-skin-promoting agent and use thereof
11/01/2012WO2012147834A1 Radiation sensitizing agent
11/01/2012WO2012147832A1 Phenyl pyrrole derivative crystal
11/01/2012WO2012147831A1 Method for manufacturing phosphonocrotonic acid derivative
11/01/2012WO2012147805A1 Brain-targeting functional nucleic acid and use thereof
11/01/2012WO2012147773A1 Novel cephem compound having catechol or pseudo-catechol structure
11/01/2012WO2012147765A1 Benzimidazole derivative having npy y5 receptor antagonist action
11/01/2012WO2012147764A1 5-membered ring aromatic heterocyclic derivative having npy y5 receptor antagonistic activity
11/01/2012WO2012147763A1 Oxazine derivative and bace 1 inhibitor containing same
11/01/2012WO2012147762A1 Pyridine derivative and bace-1 inhibitor containing same
11/01/2012WO2012147705A1 Therapeutic agent for inflammatory respiratory diseases comprising trehalose
11/01/2012WO2012147660A1 Rapidly dissolving oral tablet
11/01/2012WO2012147619A1 Blood glucose level increase inhibitor
11/01/2012WO2012147597A1 Camptocormia therapeutic agent
11/01/2012WO2012147584A1 Suspended lotion containing imidazole-type anti-fungal agent
11/01/2012WO2012147518A1 Novel 3-hydroxyisothiazole 1-oxide derivative
11/01/2012WO2012147516A1 Cyclic amide derivative
11/01/2012WO2012147470A1 Peptide for inducing regeneration of tissue and use thereof
11/01/2012WO2012147351A1 Powdered starting material, bottle cap, and container comprising said bottle cap
11/01/2012WO2012147102A1 Bioactive fractions and compounds from dalbergia sissoo for the prevention or treatment of osteo-health related disorders
11/01/2012WO2012147099A1 Pharmaceutical compositions of levodopa, carbidopa and entacapone
11/01/2012WO2012147084A2 Oxymetazoline for the treatment of ano-rectal disorders
11/01/2012WO2012147056A1 Vaginal composition based on alkyl polyglucosides
11/01/2012WO2012147035A1 Acid addition salts of risperidone and pharmaceutical compositions thereof
11/01/2012WO2012147003A1 Vitamin b1 for treatment of chronic fatigue
11/01/2012WO2012146936A1 Pyrrolnitrin derivatives
11/01/2012WO2012146933A1 Cyprodinil for use in medicine
11/01/2012WO2012146890A1 Prebiotic agent
11/01/2012WO2012146881A1 Anti-inflammatory composition for the intestine including maltitol
11/01/2012WO2012146810A1 Method for obtaining amino alcohols and chiral diamines
11/01/2012WO2012146800A1 Use of diterpenoid compounds as antiinflammatory and antitumour agents
11/01/2012WO2012146773A1 Composition for prevention and treatment of rheumatoid arthritis
11/01/2012WO2012146763A1 Pharmaceutical compositions comprising a local anaesthetic such as bupivacaine for local administration to the mouth or throat
11/01/2012WO2012146737A1 4-[(haloalkyl)(dimethyl)ammonio]butanoates and use thereof in the treatment of cardiovascular disease
11/01/2012WO2012146736A1 Use of 3-carboxy-n-ethyl-n,n-dimethylpropan-1-aminium salts in the treatment of cardiovascular disease
11/01/2012WO2012146724A2 Novel rock inhibitors
11/01/2012WO2012146706A1 Methods and pharmaceutical compositions for the treatment of hormone-refractory prostate cancers
11/01/2012WO2012146667A1 Imidazopyridine derivatives as pi3k inhibitors
11/01/2012WO2012146666A1 Pyrrolotriazinone derivatives as pi3k inhibitors
11/01/2012WO2012146659A1 Novel compound useful for the treatment of degenerative and inflammatory diseases
11/01/2012WO2012146657A1 Novel compound useful for the treatment of degenerative and inflammatory diseases
11/01/2012WO2012146644A1 Salt of an inhibitor of phosphodiesterase 10 enzyme
11/01/2012WO2012146642A1 Administration of iloprost as aerosol bolus
11/01/2012WO2012146610A1 Composition comprising aflibercept, folinic acid, 5-fluorouracil (5-fu) and irinocetan (folfiri)
11/01/2012WO2012146552A1 Pyrazolidin-3-one derivatives
11/01/2012WO2012146551A1 Ethynyl derivatives as positive allosteric modulators of the mglur5
11/01/2012WO2012146515A1 Alkaloid ester and carbamate derivatives and medicinal compositions thereof
11/01/2012WO2012146383A1 Tapentadol for preventing and treating depression and anxiety
11/01/2012WO2012146371A1 Pharmaceutically acceptable cocrystals of n-[2-(7-methoxy-1-naphtyl)ethyl]acetamide and methods of their preparation
11/01/2012WO2012146362A1 Triazole compounds as potential anti-inflammatory agents
11/01/2012WO2012146318A1 Derivatives of n- [(1h-pyrazol-1-yl) aryl] - 1h - indole or 1h - indazole - 3 - carboxamide, their preparation and their use as p2y12 antagonists
11/01/2012WO2012146314A1 Thin gelatin capsules for rapid drug release in the mouth
11/01/2012WO2012146259A1 Method for determining clinically relevant hypoxia in cancer
11/01/2012WO2012146194A1 Extracts of cynanchum sp. and active ingredients contained therein in use of arthritis treatment
11/01/2012WO2012146075A1 Inhibitor of sodium-dependent glucose transport protein and preparation method therefor and use thereof
11/01/2012WO2012146067A1 1,4-dihydropyridine -3,5-dicarboxylate derivatives, preparation methods and uses thereof
11/01/2012WO2012146057A1 Curcuminoid injection solution and intravenous injection
11/01/2012WO2012146052A1 Risperidone sustained release microsphere composition
11/01/2012WO2012146049A1 Traditional chinese medicine composition for treating oral cavity disease and the preparation technology and the quality testing method thereof
11/01/2012WO2012145981A1 Adamantane or adamantane-like compounds as antitumor agents
11/01/2012WO2012145946A1 Application of dwarf lilyturf tuber polysaccharide extract in preparation of dietary supplement, health food or medicine with the function of weight loss
11/01/2012WO2012145899A1 Ester compound, preparation method and application thereof
11/01/2012WO2012145893A1 A composition of entacopone
11/01/2012WO2012145809A1 Pharmaceutical compositions and uses thereof for the treatment and/or prevention of diseases caused by hypoestrogenism in the lower genital tract of women
11/01/2012WO2012145801A1 Nanoparticle
11/01/2012WO2012121523A3 Process for preparing pharmaceutical formulation in form of antioxidant-free solution for injection containing pemetrexed or its salt
11/01/2012WO2012115479A3 Diaminopyrimidine derivatives and processes for the preparation thereof
11/01/2012WO2012115446A3 Compound based on 5-(substituted alkyl-aminomethyl) isoxazole acting as a t-type calcium channel antagonist
11/01/2012WO2012112638A8 Ocular strips
11/01/2012WO2012112543A3 Method and apparatus for the delivery of photo-chemical (cross-linking) treatment to scleral tissue
11/01/2012WO2012111965A3 Orally administered sustained-release triple-layer pill containing tamsulosin or pharmaceutically acceptable salt thereof
11/01/2012WO2012109567A3 Treatment of angiogenesis disorders
11/01/2012WO2012109238A3 Methods for increasing immune responses using agents that directly bind to and activate ire-1
11/01/2012WO2012108689A3 Novel compound having skin-whitening, anti-oxidizing and ppar activities and medical use therefor
11/01/2012WO2012107890A3 Crystal forms of lurasidone chlorhydrate
11/01/2012WO2012106584A3 Pitavastatin salts
1 ... 972 973 974 975 976 977 978 979 980 981 982 983 984 985 986 987 988 989 990 991 992 ... 7860